ANTHELMIN PLUS Italia - Italia - Ministero della Salute

anthelmin plus

krka dd novo mesto - praziquantel, pirantel embonato, febantel - praziquantel - 175 milligrammo (i); pirantel embonato - 504 milligrammo (i); febantel - 525 milligrammo (i), febantel - 525 mg; pirantel embonato - 504 mg; praziquantel - 175 mg, febantel - 525 mg; praziquantel - 175 mg; pirantel embonato - 504 mg, praziquantel - 175 mg; febantel - 525 mg; pirantel embonato - 504 mg, febantel - 150 mg; praziquantel - 50 mg; pirantel embonato - 504 mg - febantel, combinations

Kalium chloratum 15% Sintetica fiale supplementari per perfusioni Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

kalium chloratum 15% sintetica fiale supplementari per perfusioni

sintetica sa - kalii chloridum - fiale supplementari per perfusioni - kalii chloridum 150 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. chloridum 2 mmol, kalium 2 mmol. - terapia potassica - synthetika

Kalium phosphoricum comp. Tablette Kalium phosphoricum comp. Tablette Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

kalium phosphoricum comp. tablette kalium phosphoricum comp. tablette

weleda ag - aurum metallicum praeparatum (aurum metallicum hab) praeparatum d10, kalium phosphoricum (hab) d6, ferrum-quarz (compositio e ferrum sulfuricum (praep. e siderit), quarz, mel, vinum) d2 (ph.eur.hom. 4.1.1) - kalium phosphoricum comp. tablette - aurum metallicum praeparatum (aurum metallicum hab) praeparatum d10 83 mg, kalium phosphoricum (hab) d6 83 mg, ferrum-quarz (compositio e ferrum sulfuricum (praep. e siderit), quarz, mel, vinum) d2 (ph.eur.hom. 4.1.1) 8 mg, lactosum monohydricum, tritici amylum 25 mg, calcii behenas, pro compresso 250 mg corresp. lactosum monohydricum 223 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - antroposofici

Kalydeco Uni Eropa - Italia - EMA (European Medicines Agency)

kalydeco

vertex pharmaceuticals (ireland) limited - ivacaftor - fibrosi cistica - altri prodotti per il sistema respiratorio - kalydeco tablets are indicated:as monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 e 5. in a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cftr gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t. in a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who have at least one f508del mutation in the cftr gene (see section 5. kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cftr gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 e 5. in a combination regimen with ivacaftor/tezacaftor/elexacaftor for the treatment of cystic fibrosis (cf) in paediatric patients aged 2 to less than 6 years who have at least one f508del mutation in the cftr gene.

Kalium aceticum comp. D2 Polvere orale Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

kalium aceticum comp. d2 polvere orale

weleda ag - kalium aceticum comp. (compositio ex: kalium carbonicum, acetum vini destillatum, antimonit, tinctura croci sativi, spiritus e vino, corallium rubrum) d2 (ph.eur.hom. 4.1.1) - polvere orale - kalium aceticum comp. (compositio ex: kalium carbonicum, acetum vini destillatum, antimonit, tinctura croci sativi, spiritus e vino, corallium rubrum) d2 (ph.eur.hom. 4.1.1) 1000 mg, lactosum monohydricum 990 mg, ad pulverem pro 1 g. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - antroposofici

Kalium aceticum comp. 1% Salbe Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

kalium aceticum comp. 1% salbe

weleda ag - kalium aceticum comp. m 10% - salbe - kalium aceticum comp. m 10% 100 mg, adeps lanae, alcoli adipis lanae, excipiens annuncio unguentum pro 1 g. - ohne indicatore - anthroposophische arzneimittel

Kalydeco 150 mg Compresse rivestite con film Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

kalydeco 150 mg compresse rivestite con film

vertex pharmaceuticals (ch) gmbh - ivacaftorum - compresse rivestite con film - ivacaftorum 150 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 167.2 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 132, cera carnauba, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro compresso obducto corresp. natrium 1.82 mg. - la fibrosi cistica - synthetika

Plus Kalium retard Compresse Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

plus kalium retard compresse

amino ag, fabrikation pharmazeutischer und chemischer produkte - kalii chloridum - compresse - kalii chloridum 600 mg, excipiens pro compresso. - kaliumpräparat - synthetika

Kalium aceticum comp. D6 Soluzione iniettabile (s. c.) Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

kalium aceticum comp. d6 soluzione iniettabile (s. c.)

weleda ag - kalium aceticum comp. (compositio ex: kalium carbonicum, acetum vini destillatum, antimonit, tinctura croci sativi, spiritus e vino, corallium rubrum) d6 (ph.eur.hom. 3.2.2) - soluzione iniettabile (s. c.) - zulassung gilt auch für alle höheren folgepotenzen: kalium aceticum comp. (compositio ex: kalium carbonicum, acetum vini destillatum, antimonit, tinctura croci sativi, spiritus e vino, corallium rubrum) d6 (ph.eur.hom. 3.2.2) 1 ml, natrii chloridum corresp. natrium 3 mg, lactosum monohydricum, aqua ad iniectabile, ad solutionem pro 1 ml. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - antroposofici

Co-Losartan Sandoz 50 mg/12.5 mg Compresse rivestite con film Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

co-losartan sandoz 50 mg/12.5 mg compresse rivestite con film

sandoz pharmaceuticals ag - losartanum kalicum, hydrochlorothiazidum - compresse rivestite con film - filmtablette: losartanum kalicum 50 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 26.9 mg, cellulosum microcristallinum, amylum pregelificatum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, hydroxypropylcellulosum, e 171, e 172, pro compresso obducto. - l'angiotensina-ii-rezeptor-antagonista/diuretikum - synthetika